Your browser doesn't support javascript.
loading
GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action.
Lee, Seunghun P; Qi, Jenson; Xu, Guozhang; Rankin, Matthew M; Littrell, James; Xu, June Zhi; Bakaj, Ivona; Pocai, Alessandro.
Affiliation
  • Lee SP; Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, United States.
  • Qi J; Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, United States.
  • Xu G; Discovery Sciences, Janssen Research & Development, Spring House, PA, United States.
  • Rankin MM; Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, United States.
  • Littrell J; Discovery Sciences, Janssen Research & Development, Spring House, PA, United States.
  • Xu JZ; Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, United States.
  • Bakaj I; Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, United States.
  • Pocai A; Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, PA, United States.
Front Endocrinol (Lausanne) ; 12: 652628, 2021.
Article in En | MEDLINE | ID: mdl-34054727

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucagon-Like Peptide 1 / G-Protein-Coupled Receptor Kinase 1 Limits: Animals / Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2021 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glucagon-Like Peptide 1 / G-Protein-Coupled Receptor Kinase 1 Limits: Animals / Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2021 Document type: Article Affiliation country: United States